Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | TLR8 | Q9NR97 | 4/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | DYRK1A | Q13627 | 3/20 | 0.40 |
| ▸ | CDK9 | P50750 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.40 |
| ▸ | HRH1 | P35367 | 2/20 | 0.38 |
| ▸ | BCDIN3D | Q7Z5W3 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4451104 | 0.87 | HTR1B (0.50) | HTR1BCYP1A2CYP2D6DYRK1ACDK9 | |
| SCHEMBL25742668 | 0.84 | HTR1B (0.47) | HTR1BCYP1A2CYP2D6CYP2C19CHRM2 | |
| SCHEMBL7472414 | 0.83 | HTR1B (0.51) | HTR1BTLR8CHRM2CHRM1CHRM3 | |
| SCHEMBL826348 | 0.83 | HTR1B (0.46) | HTR1BMAOACHRM2CHRM1CHRM3 | |
| SCHEMBL28493440 | 0.81 | HTR1B (0.50) | HTR1BTLR8CHRM2CHRM1CHRM3 | |
| SCHEMBL1603347 | 0.81 | HTR1B (0.53) | HTR1BCHRM2CHRM1CHRM3CYP2A6 | |
| SCHEMBL28326818 | 0.81 | HTR1B (0.47) | HTR1BCHRM2CHRM1CHRM3DYRK1A | |
| SCHEMBL31164857 | 0.80 | CA2 (0.55) | HTR1BDYRK1ACDK9CYP2A6BCDIN3D | |
| SCHEMBL111709 | 0.80 | CA2 (0.55) | HTR1BDYRK1ACDK9CYP2A6BCDIN3D | |
| Ammonia Solution, Strong SCHEMBL9564542 | 0.79 | HTR1B (0.51) | HTR1BCHRM2CHRM1CHRM3CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0533265-A1 | Process of making substituted azetidinones | MERCK & CO. INC. (US) | 1993-03-24 | — | — | EP | disclosed |
| US-5149838-A | Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents | MERCK & CO., INC. (US) | 1992-09-22 | — | — | US | disclosed |